Health Catalyst, Inc.
HCAT
$1.10
-$0.12-9.50%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.48% | 4.64% | 5.55% | 4.88% | 3.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.48% | 4.64% | 5.55% | 4.88% | 3.60% |
| Cost of Revenue | -5.03% | 2.07% | 5.30% | 4.18% | 2.28% |
| Gross Profit | 9.06% | 7.63% | 5.84% | 5.72% | 5.17% |
| SG&A Expenses | -4.91% | -5.96% | -10.45% | -14.98% | -10.85% |
| Depreciation & Amortization | 21.89% | 15.47% | 8.58% | 3.53% | -1.88% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.09% | -1.14% | -1.94% | -4.91% | -5.45% |
| Operating Income | 34.90% | 28.30% | 32.04% | 39.39% | 36.23% |
| Income Before Tax | -156.27% | -34.52% | -15.82% | 31.31% | 41.28% |
| Income Tax Expenses | 115.02% | 745.64% | 15.84% | 8.75% | -6.46% |
| Earnings from Continuing Operations | -156.07% | -35.99% | -15.82% | 31.16% | 41.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -156.07% | -35.99% | -15.82% | 31.16% | 41.17% |
| EBIT | 34.90% | 28.30% | 32.04% | 39.39% | 36.23% |
| EBITDA | 108.00% | 69.51% | 61.01% | 64.78% | 55.44% |
| EPS Basic | -119.42% | -17.17% | -0.98% | 37.88% | 44.95% |
| Normalized Basic EPS | 17.18% | 9.89% | 15.16% | 31.86% | 34.06% |
| EPS Diluted | -119.42% | -17.17% | -0.98% | 37.88% | 44.95% |
| Normalized Diluted EPS | 17.18% | 9.89% | 15.16% | 31.86% | 34.06% |
| Average Basic Shares Outstanding | 16.14% | 14.89% | 12.46% | 9.58% | 6.68% |
| Average Diluted Shares Outstanding | 16.14% | 14.89% | 12.46% | 9.58% | 6.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |